ARCHIVES

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

Dileep Bal Elected Cancer Society President, Young Is President-Elect, Baity Leads Board.

December 8, 2000

In Brief: Yarbros To Move Frm Missouri To Illinois; Canellos Elected Fellow Of Royal College

February 21, 1992

Richard Bloch, advocate for patient information services, dead at 78.

July 30, 2004